Adaptive Biotechnologies to Report First Quarter Financial Results on May 4, 2022
April 05 2022 - 3:30PM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a
commercial-stage biotechnology company that aims to translate the
genetics of the adaptive immune system into clinical products to
diagnose and treat disease, today announced it will report
financial results for the first quarter 2022 after market close on
Wednesday, May 4, 2022. Company management will webcast a
corresponding conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.adaptivebiotech.com. The
webcast will be archived and available for replay within 24 hours
after the event.
About Adaptive BiotechnologiesAdaptive
Biotechnologies is a commercial-stage biotechnology company
focused on harnessing the inherent biology of the adaptive immune
system to transform the diagnosis and treatment of disease. We
believe the adaptive immune system is nature’s most finely tuned
diagnostic and therapeutic for most diseases, but the inability to
decode it has prevented the medical community from fully leveraging
its capabilities. Our proprietary immune medicine platform reveals
and translates the massive genetics of the adaptive immune system
with scale, precision and speed to develop products in our Immune
Medicine and Minimal Residual Disease (MRD) businesses. We have
three commercial products and a robust clinical pipeline to
diagnose, monitor and enable the treatment of diseases such as
cancer, autoimmune conditions and infectious diseases. For more
information, please visit adaptivebiotech.com and follow
us on www.twitter.com/adaptivebiotech.
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor Relations201-396-1687Carrie
Mendivil, Gilmartin Groupinvestors@adaptivebiotech.com
ADAPTIVE MEDIALaura Cooper, Senior Director,
Corporate Communications206-693-2042lcooper@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2024 to May 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From May 2023 to May 2024